enVVeno Medical (NVNO) Profit After Tax (2017 - 2026)

enVVeno Medical's Profit After Tax history runs 10 years deep, the most recent figure standing at -$3.8 million for Q1 2026.

• On a quarterly basis, Profit After Tax rose 14.52% year-over-year to -$3.8 million in Q1 2026; TTM through Mar 2026 was -$18.8 million, a 11.78% increase from a year earlier, with the FY2025 full-year figure at -$19.5 million, up 10.76% from the prior year.
• Profit After Tax retreated to -$3.8 million in Q1 2026 per NVNO's latest filing, from -$3.7 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$3.7 million in Q4 2025 and bottomed at -$7.1 million in Q2 2022.
• The 5-year median for Profit After Tax is -$5.6 million (2024), against an average of -$5.5 million.
• Across the five-year window, Profit After Tax sank 196.97% in 2022 and soared 40.02% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$6.2 million in 2022, then climbed by 8.59% to -$5.6 million in 2023, then retreated by 10.27% to -$6.2 million in 2024, then soared by 40.02% to -$3.7 million in 2025, then declined by 3.02% to -$3.8 million in 2026.
• Per Business Quant, the three latest NVNO Profit After Tax figures stand at -$3.8 million (Q1 2026), -$3.7 million (Q4 2025), and -$4.5 million (Q3 2025).